UBS Group Portfolio holdings
UBS Group AG, formed through the 1998 merger of Union Bank of Switzerland and Swiss Bank Corporation with roots dating back to 1862, is a Swiss multinational investment bank and financial services firm headquartered in Zurich. Renowned for its dominance in wealth management, UBS serves high-net-worth individuals and families globally, managing trillions in assets, while also offering investment banking, asset management, and retail banking services in Switzerland. The firm has weathered significant challenges, including a major bailout during the 2008 financial crisis, but has since refocused on stability and sustainable growth, emphasizing digital transformation and ESG (environmental, social, governance) investing. With a strong European base and a global reach, UBS remains a cornerstone of the international financial landscape.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Tesla
TSLA
|
+$388M |
| 2 |
iShares 20+ Year Treasury Bond ETF
TLT
|
+$359M |
| 3 |
ExxonMobil
XOM
|
+$284M |
| 4 |
TSMC
TSM
|
+$259M |
| 5 |
iShares China Large-Cap ETF
FXI
|
+$239M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$911M |
| 2 |
iShares Core S&P 500 ETF
IVV
|
+$825M |
| 3 |
UBS Group
UBS
|
+$683M |
| 4 |
Invesco QQQ Trust
QQQ
|
+$381M |
| 5 |
Willis Towers Watson
WTW
|
+$375M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 13.08% |
| 2 | Financials | 7.19% |
| 3 | Healthcare | 6.35% |
| 4 | Consumer Discretionary | 5.55% |
| 5 | Industrials | 4.21% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
IMGN
3126
DELISTED
Immunogen Inc
IMGN
| $2.75M | ﹤0.01% |
578,502
+276,405
| +91% | +$1.53M |
|
|
OEFA
3127
ALPS O'Shares International Developed Quality Dividend ETF
OEFA
$37.7M
| $2.75M | ﹤0.01% |
106,220
+18,143
| +21% | +$482K |
|
|
IBDD
3128
DELISTED
iShares iBonds Mar 2023 Term Corporate ETF
IBDD
| $2.75M | ﹤0.01% |
103,305
+93,393
| +942% | +$2.49M |
|
3129
ArcelorMittal
MT
$55.6B
| $2.74M | ﹤0.01% |
85,712
-200,932
| -70% | -$6.44M |
|
3130
iShares MSCI USA Size Factor ETF
SIZE
$444M
| $2.74M | ﹤0.01% |
21,009
+15,747
| +299% | +$2.03M |
|
|
MYJ
3131
DELISTED
Blackrock Muni Yield New Jersey Fund, Inc.
MYJ
| $2.74M | ﹤0.01% |
204,549
+23,419
| +13% | +$333K |
|
|
LGV
3132
DELISTED
Longview Acquisition Corp. II
LGV
| $2.73M | ﹤0.01% |
280,265
+267,091
| +2,027% | +$2.6M |
|
3133
Albany International
AIN
$1.79B
| $2.73M | ﹤0.01% |
32,380
-77,591
| -71% | -$6.68M |
|
3134
Grab
GRAB
$15.2B
| $2.73M | ﹤0.01% |
779,703
+562,836
| +260% | +$2.85M |
|
3135
WisdomTree Trust WisdomTree China ex-State-Owned Enterprises Fund
CXSE
$500M
| $2.72M | ﹤0.01% |
68,104
-20,764
| -23% | -$938K |
|
3136
RLX Technology
RLX
$2.43B
| $2.72M | ﹤0.01% |
1,519,478
-45,130
| -3% | -$134K |
|
3137
Nuveen New York Municipal Value Fund
NNY
$157M
| $2.72M | ﹤0.01% |
301,237
+29,884
| +11% | +$282K |
|
|
KZR
3138
DELISTED
Kezar Life Sciences
KZR
| $2.71M | ﹤0.01% |
16,291
+6,479
| +66% | +$930K |
|
3139
Supernus Pharmaceuticals
SUPN
$2.79B
| $2.71M | ﹤0.01% |
83,764
-15,235
| -15% | -$467K |
|
3140
Tenable Holdings
TENB
$4.17B
| $2.7M | ﹤0.01% |
46,778
-22,102
| -32% | -$1.14M |
|
3141
Forestar Group
FOR
$1.49B
| $2.7M | ﹤0.01% |
152,022
-1,703
| -1% | -$31.9K |
|
3142
iShares Russell 2500 ETF
SMMD
$3.74B
| $2.7M | ﹤0.01% |
43,224
-21,456
| -33% | -$1.32M |
|
3143
Portland General Electric
POR
$5.71B
| $2.69M | ﹤0.01% |
48,767
-24,156
| -33% | -$1.27M |
|
3144
iShares Core International Aggregate Bond Fund
IAGG
$11.4B
| $2.68M | ﹤0.01% |
51,486
-6,878
| -12% | -$366K |
|
3145
Blue Owl Capital
OBDC
$5.77B
| $2.68M | ﹤0.01% |
181,635
-149,880
| -45% | -$2.2M |
|
3146
Melco Resorts & Entertainment
MLCO
$2.15B
| $2.68M | ﹤0.01% |
351,031
-509,353
| -59% | -$4.9M |
|
|
UNIT
3147
Uniti Group
UNIT
$2.28B
| $2.68M | ﹤0.01% |
194,784
+61,271
| +46% | +$776K |
|
|
EWSC
3148
DELISTED
Invesco S&P SmallCap 600 Equal Weight ETF
EWSC
| $2.68M | ﹤0.01% |
33,269
+1,841
| +6% | +$148K |
|
|
SGMO
3149
DELISTED
SANGAMO THERAPEUTICS INC
SGMO
| $2.67M | ﹤0.01% |
460,380
+51,968
| +13% | +$309K |
|
3150
H.B. Fuller
FUL
$3.34B
| $2.67M | ﹤0.01% |
40,456
-10,146
| -20% | -$715K |
|
Similar funds
UBS Group's Q1 2022 Portfolio in Review
As of Q1 2022, UBS Group held 11,668 positions worth $300B, down 14% from $349B the previous quarter. Its ten largest holdings account for 13% of the portfolio.
UBS Group withdrew a net $29.5B in Q1 2022, closing 1,161 positions and reducing 5,174 holdings. Its most notable exit was Xilinx Inc, an estimated $186M position sold in full.
By sector, the portfolio is most concentrated in Technology at 13% of assets, up from 12% a quarter earlier, followed by Financials and Healthcare.
Against the trend, UBS Group opened a new position in Shell worth $66.6M.
- UBS Group's largest Q1 2022 buy was Shell: 1,213,213 shares worth $66.6M.
- UBS Group added most to Tesla in Q1 2022, an estimated $388M increase.
- UBS Group's biggest Q1 2022 reduction was State Street SPDR S&P 500 ETF Trust, cutting an estimated $911M.
- UBS Group fully exited Xilinx Inc in Q1 2022, selling an estimated $186M.
- UBS Group's ten largest holdings make up 13% of its $300B portfolio in Q1 2022.
- UBS Group opened 1,181 new positions and closed 1,161 in Q1 2022.
- UBS Group's portfolio value fell 14% quarter-over-quarter to $300B.
Based on UBS Group's 13F filing for Q1 2022, filed 16 May 2022.